Stocks analysis

Analysis for MS

$182.10 +0.59 (+0.33%)
  • 📈 Growth — 28/30
  • 💰 Profitability — 16/20
  • 🏦 Financial Health — 12/20
  • 💵 Valuation — 14/20
  • ⚠️ Risk — 7/10
Overall Score: 73/100

Summary:


📈 Growth & Financial Trajectory

Over the eight quarters from 2024 Q2 to 2026 Q2, Morgan Stanley's revenues rose from $16.223B to $21.348B, a start-to-end gain of about 31.6%. Net income increased from $3.724B to $5.653B, up roughly 52%. The sequence generally trends higher, with a mid-period dip in 2024 Q3, then a steady ascent into 2026 Q2, establishing a higher base than at the start.

💰 Margins & Cash Flow

  • Operating margin averaged around 34% across the period, with a range from the low- to mid-20s (2024 Q3) to about 38% (2025 Q3).
  • Cash flow: operating cash flow was negative in several quarters (e.g., 2026 Q1: -$7.098B; 2026 Q2: -$2.747B). Investing cash flow was negative, while financing cash flow was large and positive (e.g., 2026 Q1 +$36.46B, 2026 Q2 +$37.06B); net cash flow turned positive in these periods thanks to financing.
  • The observed net cash flow figures reflect a financing-driven liquidity support while operations and investments yielded mixed signs.

🛡️ Balance Sheet & Liquidity

  • Assets remained robust, ranging roughly from $1.21T to $1.68T (e.g., Q2 2026 $1.675T, Q4 2025 $1.581T).
  • Equity attributable to parent stood around $101B–$118B (e.g., Q2 2026 $117.44B, Q4 2025 $112.65B).
  • Long-term debt ran $269B–$383B (e.g., Q2 2026 $383.156B, Q4 2024 $291.223B). The equity-to-asset mix sits near 7%, indicating solid capitalization for a large bank and resilience supported by ample current liabilities and liquidity.

⚠️ Key Drivers & Risks

  • Drivers: Wealth management and capital markets activity; net interest income exposure to rate changes.
  • Risks: Market cyclicality and regulatory/rate environment sensitivity.

📊 Key Financial Fundamentals

Valuation Multiples
Market Cap $317.91B
P/E Ratio 15.77
Forward P/E 15.73
P/S Ratio 2.47
P/B Ratio 2.82
EV / EBITDA 37.62
Profitability & Returns
Gross Margin 56.72%
Operating Margin 20.30%
Net Margin 15.65%
ROE 17.83%
ROIC 1.96%
Financial Health & Liquidity
Current Ratio 0.35
Quick Ratio 0.35
Financial Scale & Cash Flow
Revenue $128.80B
Net Income $20.16B
FCF Yield 6.92%
Free Cash Flow $21.99B
Total Debt To Equity 8.52